NCB 0846Alternative Names: NCB-0846
Latest Information Update: 08 Jul 2016
At a glance
- Originator Carna Biosciences
- Mechanism of Action Germinal centre kinase inhibitors; Wnt signalling pathway inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 08 Jul 2016 Preclinical trials in Cancer in USA (unspecified route)